Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Weight Loss 2Carcinoma, Non-Small-Cell Lung 2Cachexia 2Anorexia 2Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1

Interventions

Gemcitabine 679130-nm albumin-bound paclitaxel 198Fluorouracil 186Oxaliplatin 175Albumin-Bound Paclitaxel 151Capecitabine 137Leucovorin 131Irinotecan 113Radiotherapy 95Taxes 83pembrolizumab 80Cisplatin 72Erlotinib Hydrochloride 69Radiosurgery 67Nivolumab 56Bevacizumab 54Drug Therapy 52Cyclophosphamide 49Magnetic Resonance Spectroscopy 46folfirinox 42Docetaxel 41Cetuximab 40Specimen Handling 37irinotecan sucrosofate 36S 1 (combination) 36Biopsy 31Radiation 29Paclitaxel 29Ipilimumab 27durvalumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pancreatic Neoplasms × anamorelin × Clear all
NCT04844970 2025-11-17

Anamorelin Study for Advanced Pancreatic Cancer

Lahey Clinic

Phase 2 Terminated
4 enrolled 12 charts
Gastrointestinal

Anorexia, Cachexia, Pancreatic Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡